Meridian Medical Technologies, LLC, and the European Commission’s DG HERA Sign Agreement for 13 Countries From the EEA to Purchase Tecovirimat SIGA

Contributed by: Business Wire

Tags

Other Defense
Infectious Diseases
Contracts
Biotechnology
Other Health
Health
Pharmaceutical
General Health
Defense
Meridian Medical Technologies, LLC

More Like This

PR Newswire associated0

Huma signs partnership with Merck KGaA, Darmstadt, Germany to support cancer care

PR Newswire associated0

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

PR Newswire associated0

Zentiva joins the Critical Medicines Alliance to enhance EU Medicine Supply

Merck operators monitoring viral vector production in a bioreactor in Merck's Carlsbad, California manufacturing facility. (Photo: Business Wire)

Merck Signs Definitive Agreement to Acquire Mirus Bio, Furthering Ambition to Be a Leading Supplier for Viral Vector Manufacturing

Business Wire logo

Kindeva Global Health Security Donates ATNAA to Ukraine Through the European Commission's rescEU and Governmental Strategic Reserves Agency (RARS)

Alira Health Releases The 2024 Global Medtech Contract Manufacturing Report

Photocure Partner Asieris to present First-ever Results of the international multicenter Phase III clinical Study for Cevira, a non-surgical treatment for cervical HSIL, at the 2024 EUROGIN

Photocure Partner Asieris announces positive international Phase III clinical trial results for Cevira and data presentations at the 2024 EUROGIN Congress and SGO Annual Meeting